HK1204545A1 - Compositions and methods for the treatment of bone voids and open fractures - Google Patents
Compositions and methods for the treatment of bone voids and open fracturesInfo
- Publication number
- HK1204545A1 HK1204545A1 HK15105176.8A HK15105176A HK1204545A1 HK 1204545 A1 HK1204545 A1 HK 1204545A1 HK 15105176 A HK15105176 A HK 15105176A HK 1204545 A1 HK1204545 A1 HK 1204545A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- compositions
- treatment
- methods
- open fractures
- bone voids
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/12—Phosphorus-containing materials, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3608—Bone, e.g. demineralised bone matrix [DBM], bone powder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/22—Lipids, fatty acids, e.g. prostaglandins, oils, fats, waxes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
- A61L2300/406—Antibiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Botany (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polymers & Plastics (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261678655P | 2012-08-02 | 2012-08-02 | |
US201261739792P | 2012-12-20 | 2012-12-20 | |
US201361778791P | 2013-03-13 | 2013-03-13 | |
PCT/IL2013/050657 WO2014020610A1 (en) | 2012-08-02 | 2013-08-01 | Compositions and methods for the treatment of bone voids and open fractures |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1204545A1 true HK1204545A1 (en) | 2015-11-27 |
Family
ID=50027362
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15105176.8A HK1204545A1 (en) | 2012-08-02 | 2015-05-29 | Compositions and methods for the treatment of bone voids and open fractures |
Country Status (19)
Country | Link |
---|---|
US (1) | US9173976B2 (xx) |
EP (1) | EP2879620B1 (xx) |
JP (1) | JP6182213B2 (xx) |
KR (1) | KR101883807B1 (xx) |
CN (1) | CN104519834B (xx) |
AU (1) | AU2013298102B2 (xx) |
BR (1) | BR112015001843B1 (xx) |
CA (1) | CA2880130C (xx) |
EA (1) | EA027543B1 (xx) |
ES (1) | ES2802025T3 (xx) |
HK (1) | HK1204545A1 (xx) |
IL (1) | IL236823A0 (xx) |
IN (1) | IN2015DN01553A (xx) |
MX (1) | MX366048B (xx) |
NZ (1) | NZ704066A (xx) |
PH (1) | PH12015500226B1 (xx) |
SG (1) | SG11201500403RA (xx) |
WO (1) | WO2014020610A1 (xx) |
ZA (1) | ZA201500559B (xx) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102466337B1 (ko) * | 2014-10-02 | 2022-11-14 | 폴리피드 엘티디. | 임플란트 주위염의 치료 방법 |
LT3200748T (lt) | 2014-10-02 | 2021-12-10 | Polypid Ltd. | Kompozicijos ir būdai chirurginės operacijos vietos infekcijų gydymui ir profilaktikai |
US10485902B2 (en) | 2015-08-28 | 2019-11-26 | Thomas Jefferson University | Antibiotic drug release sheath |
US10029031B2 (en) * | 2015-10-28 | 2018-07-24 | Warsaw Orthopedic, Inc. | Bone void filler having sustained therapeutic agent release |
FR3064482B1 (fr) * | 2017-04-03 | 2020-11-13 | Horus Pharma | Composition topique de doxycycline |
WO2020163425A1 (en) * | 2019-02-05 | 2020-08-13 | Flightpath Biosciences, Inc. | Azlocillin and disulfiram-based formulations and methods of use |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6277413B1 (en) * | 1998-07-17 | 2001-08-21 | Skyepharma, Inc. | Biodegradable compositions for the controlled release of encapsulated substances |
US9457056B2 (en) * | 2007-12-04 | 2016-10-04 | Ben-Gurion University Of The Negev Research And Development Authority | Peptides comprising alternating hydrophobic and anionic amino acids for treatment of osteoporosis |
JP5681626B2 (ja) * | 2008-07-14 | 2015-03-11 | ポリーペイド リミテッドPolypid Ltd. | 徐放性薬剤キャリア組成物 |
WO2011007353A1 (en) * | 2009-07-14 | 2011-01-20 | Polypid Ltd. | Sustained-release drug carrier composition |
-
2013
- 2013-08-01 EA EA201590049A patent/EA027543B1/ru not_active IP Right Cessation
- 2013-08-01 US US14/418,138 patent/US9173976B2/en active Active
- 2013-08-01 CN CN201380040312.9A patent/CN104519834B/zh active Active
- 2013-08-01 KR KR1020157005232A patent/KR101883807B1/ko active IP Right Grant
- 2013-08-01 EP EP13826014.6A patent/EP2879620B1/en active Active
- 2013-08-01 BR BR112015001843-2A patent/BR112015001843B1/pt active IP Right Grant
- 2013-08-01 CA CA2880130A patent/CA2880130C/en active Active
- 2013-08-01 ES ES13826014T patent/ES2802025T3/es active Active
- 2013-08-01 SG SG11201500403RA patent/SG11201500403RA/en unknown
- 2013-08-01 MX MX2015001365A patent/MX366048B/es active IP Right Grant
- 2013-08-01 AU AU2013298102A patent/AU2013298102B2/en active Active
- 2013-08-01 WO PCT/IL2013/050657 patent/WO2014020610A1/en active Application Filing
- 2013-08-01 NZ NZ704066A patent/NZ704066A/en unknown
- 2013-08-01 JP JP2015524903A patent/JP6182213B2/ja active Active
-
2015
- 2015-01-20 IL IL236823A patent/IL236823A0/en active IP Right Grant
- 2015-01-26 ZA ZA2015/00559A patent/ZA201500559B/en unknown
- 2015-02-02 PH PH12015500226A patent/PH12015500226B1/en unknown
- 2015-02-25 IN IN1553DEN2015 patent/IN2015DN01553A/en unknown
- 2015-05-29 HK HK15105176.8A patent/HK1204545A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
PH12015500226A1 (en) | 2015-04-06 |
WO2014020610A1 (en) | 2014-02-06 |
CA2880130C (en) | 2019-09-24 |
MX2015001365A (es) | 2015-09-07 |
AU2013298102B2 (en) | 2017-09-07 |
AU2013298102A1 (en) | 2015-02-12 |
JP2015527131A (ja) | 2015-09-17 |
EP2879620A1 (en) | 2015-06-10 |
KR20150038488A (ko) | 2015-04-08 |
IN2015DN01553A (xx) | 2015-07-03 |
KR101883807B1 (ko) | 2018-07-31 |
BR112015001843B1 (pt) | 2021-05-11 |
ZA201500559B (en) | 2016-12-21 |
MX366048B (es) | 2019-06-26 |
CN104519834B (zh) | 2016-10-12 |
US9173976B2 (en) | 2015-11-03 |
US20150202349A1 (en) | 2015-07-23 |
NZ704066A (en) | 2017-06-30 |
SG11201500403RA (en) | 2015-02-27 |
IL236823A0 (en) | 2015-03-31 |
BR112015001843A2 (pt) | 2017-07-04 |
ES2802025T3 (es) | 2021-01-15 |
EP2879620A4 (en) | 2016-04-13 |
EA201590049A1 (ru) | 2015-08-31 |
EA027543B1 (ru) | 2017-08-31 |
JP6182213B2 (ja) | 2017-08-16 |
PH12015500226B1 (en) | 2015-04-06 |
CN104519834A (zh) | 2015-04-15 |
EP2879620B1 (en) | 2020-04-22 |
CA2880130A1 (en) | 2014-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL261768B (en) | Devices and methods for tissue treatment | |
IL266582A (en) | Compositions and methods for the treatment of hemoglobinopathies | |
IL231510A0 (en) | Preparations for the treatment of bone diseases and broken bones | |
EP2603202A4 (en) | COMPOSITIONS AND METHOD FOR THE TREATMENT OF TAUOPATHIES | |
EP2819620A4 (en) | METHOD AND APPARATUS FOR TREATING BONE FRACTURES, INCLUDING THE USE OF COMPOSITE IMPLANTS | |
EP2958936A4 (en) | METHOD AND COMPOSITIONS FOR TREATING CORI DISEASE | |
IL238177A0 (en) | Methods and preparations for the treatment of cancer | |
EP2688594A4 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER | |
ZA201408056B (en) | Compositions and methods for the treatment of mucositis | |
EP2544655A4 (en) | COMPOSITIONS AND METHODS FOR TREATING SKIN | |
IL225793A0 (en) | Methods and preparations for curing insulin-related medical conditions | |
HK1204545A1 (en) | Compositions and methods for the treatment of bone voids and open fractures | |
IL234606B (en) | Innovative methods and compounds for the treatment of diseases | |
EP2911660A4 (en) | COMPOSITIONS AND METHODS FOR TREATING STROGEN-RELATED MEDICAL DISORDERS | |
IL239374B (en) | Preparations and methods for treating brain tumors | |
EP2912033A4 (en) | COMPOSITIONS AND METHODS FOR TREATING ESTROGEN-MEDIATED ILLNESSES | |
HK1208598A1 (en) | Methods and compositions for treating pain | |
ZA201408055B (en) | Compositions and methods for the treatment of local pain | |
HK1220374A1 (zh) | 用於治療碳氧血紅蛋白血症的組合物和方法 | |
EP2879495A4 (en) | COMPOSITIONS AND METHODS OF TREATING NEUROPSYCHOLOGICAL DEFICIENCIES | |
EP2845598A4 (en) | COMPOSITION AND METHOD FOR THE PROPHYLAXIS AND TREATMENT OF ATYPICAL OSTEOPOROSIS | |
EP2928456A4 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER | |
EP2875820A4 (en) | COMPOSITION AND METHOD FOR PROPHYLAXIS AND TREATMENT OF OSTEOPOROSIS AND BONE BREAKS | |
EP2800568A4 (en) | COMPOSITIONS, USE METHOD AND TREATMENT METHOD THEREFOR | |
EP2547368A4 (en) | METHOD AND COMPOSITIONS FOR CANCER TREATMENT |